Clinical trials · Boise, ID
Recurrent Lung Non-Small Cell Carcinoma clinical trials in Boise
We’re tracking 8 recruiting recurrent lung non-small cell carcinoma studies with a site in or near Boise — including Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Boise
- NCT06116682RecruitingPhase 2
Targeted treatment for MET-positive advanced lung cancer
This trial tests a targeted therapy for people with advanced non-small cell lung cancer whose tumors have extra copies of the MET gene. It's for those whose cancer has progressed after at least one prior treatment.
Boise, IdahoAges 18 years+ - NCT06616584RecruitingPhase 2/Phase 3
Cemiplimab plus standard care for advanced lung cancer after prior treatments
This trial tests whether adding the immunotherapy drug cemiplimab to standard treatment can help people with advanced lung cancer that has already progressed after both platinum chemo and a prior immunotherapy. It is designed for those who responded to their first immunotherapy for at least 12 weeks before the cancer started growing again.
Boise, IdahoAges 18 years+ - NCT05642572RecruitingPhase 2
Test drug combinations for EGFR- and MET-changed lung cancer
This Phase 2 trial tests combinations of targeted medicines to treat advanced non-small cell lung cancer (NSCLC) that has changes in both EGFR and MET genes. It is for people whose cancer continued to grow even after treatment with osimertinib, the most recent therapy.
Boise, IdahoAges 18 years+ - NCT06031688RecruitingPhase 2
Targeted treatment for lung cancer with a MET gene change
This trial tests a targeted drug for advanced non-small cell lung cancer that has a specific genetic change called MET exon 14 skipping. It aims to see if the drug can shrink tumors or slow the cancer's growth, and may help people who have or haven't had prior treatment.
Boise, IdahoAges 18 minutes+ - NCT06096844RecruitingPhase 3
Chemo plus immunotherapy vs immunotherapy alone for older adults with advanced lung cancer
This trial compares chemotherapy combined with immunotherapy to immunotherapy alone for adults 70 and older with advanced non-small cell lung cancer that has a specific protein level (PD-L1 1-49%). It aims to find which treatment works better for this group.
Boise, IdahoAges 70 years+ - NCT06793215RecruitingPhase 3
Divarasib plus pembrolizumab for KRAS G12C lung cancer
This trial compares a new targeted drug (divarasib) combined with an immunotherapy (pembrolizumab) versus standard chemotherapy plus immunotherapy for people with advanced lung cancer that has a specific KRAS G12C mutation. It aims to see if the new combination works better and is safe.
Boise, IdahoAges 18 years+ - NCT04181060RecruitingPhase 3
Osimertinib alone or with bevacizumab for EGFR-mutant lung cancer
This Phase 3 trial tests whether starting osimertinib with or without bevacizumab helps people with advanced EGFR-mutant lung cancer live longer and control the cancer better. Your EGFR mutation test result and past treatments are key to whether you can join.
Boise, IdahoAges 18 years+ - NCT03191149RecruitingPhase 2
Osimertinib for lung cancer with an EGFR exon 20 change
This Phase 2 study tests osimertinib (a targeted lung cancer pill) in people with advanced non-small cell lung cancer (NSCLC) whose tumors have an EGFR exon 20 insertion. It aims to see how well osimertinib works for this specific EGFR mutation and how safe it is.
Boise, IdahoAges 18 years+
Hear when a new Recurrent Lung Non-Small Cell Carcinoma trial opens near Boise, ID
We’ll email you when one opens near Boise, ID — at most once a week, no account needed, unsubscribe anytime.
Recurrent Lung Non-Small Cell Carcinoma trials in other cities
Where these studies are running near Boise
Institutions with a site for the recruiting recurrent lung non-small cell carcinoma studies listed above.
- Saint Alphonsus Cancer Care Center-Boise · 7 studies
- Saint Alphonsus Cancer Care Center-Caldwell · 7 studies
- Saint Alphonsus Cancer Care Center-Nampa · 7 studies
- Saint Luke's Cancer Institute - Boise · 4 studies
- Idaho Urologic Institute-Meridian · 3 studies
- Saint Luke's Cancer Institute - Fruitland · 3 studies
- Saint Luke's Cancer Institute - Meridian · 3 studies
- Saint Luke's Cancer Institute - Nampa · 3 studies
What taking part in a recurrent lung non-small cell carcinoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recurrent lung non-small cell carcinoma studies in Idaho.
Common questions
- Are there recurrent lung non-small cell carcinoma clinical trials near Boise?
- Yes. We're currently tracking 8 recruiting recurrent lung non-small cell carcinoma studies with a site near Boise, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent lung non-small cell carcinoma study near Boise?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Boise to take part?
- Not necessarily. These studies have a site near Boise, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent lung non-small cell carcinoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent lung non-small cell carcinoma studies open near Boise regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.